ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,622Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 2343

$725K Total Retail Price of All Prescriptions

Rank: 300 out of 2343

560 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 560 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 560 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 17,407 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 930 892 1 1
LISINOPRIL 908 880 2 3
LEVOTHYROXINE SODIUM 882 845 3 2
WARFARIN SODIUM 514 494 4 8
HYDROCODONE-ACETAMINOPHEN 488 470 S3 5 13
OMEPRAZOLE 483 445 6 4
FUROSEMIDE 461 433 7 6
METOPROLOL TARTRATE 427 389 8 7
METOPROLOL SUCCINATE 408 378 9 14
ALENDRONATE SODIUM 361 356 10 28
AMLODIPINE BESYLATE 359 348 11 5
CITALOPRAM HBR 355 336 12 17
ATENOLOL 331 300 13 12
METFORMIN HCL 329 305 14 9
LOVASTATIN 321 315 15 47
POLYETHYLENE GLYCOL 3350 311 310 16 54
CARVEDILOL 261 243 17 27
ZETIA 249 247 18 52
LOSARTAN POTASSIUM 232 220 19 19
HYDROCHLOROTHIAZIDE 228 228 20 11
TRAMADOL HCL 216 208 21 25
TRIAMTERENE-HCTZ 196 173 22 57
ATORVASTATIN CALCIUM 193 188 23 10
POTASSIUM CHLORIDE 188 172 24 18
ALLOPURINOL 188 188 24 31
GABAPENTIN 187 164 26 16
FENOFIBRATE 183 165 27 94
ISOSORBIDE MONONITRATE ER 164 164 28 32
CRESTOR 157 149 29 30
PREDNISONE 152 146 30 37
CLOPIDOGREL 151 145 31 26
NYSTATIN 148 120 32 172
KLOR-CON M20 141 139 33 44
FLUTICASONE PROPIONATE 135 111 34 46
DIGOXIN 134 125 35 35
EVISTA 124 124 36 128
PREMARIN 123 108 R 37 286
OXYBUTYNIN CHLORIDE ER 120 108 38 149
CHLORTHALIDONE 120 116 38 183
LANTUS 116 116 40 51
TRIAMTERENE-HYDROCHLOROTHIAZID 109 96 41 263
PANTOPRAZOLE SODIUM 108 100 42 22
OXYCODONE-ACETAMINOPHEN 100 95 S2 43 49
ZOLPIDEM TARTRATE 100 89 43 24
FENTANYL 96 96 S2 45 69
PLAVIX 95 94 46 38
NOVOLOG 95 92 46 110
CLONIDINE HCL 92 73 48 70
MORPHINE SULFATE ER 88 75 S2 49 142
INSULIN SYRINGE 88 87 49 102
SERTRALINE HCL 88 67 49 20
QUETIAPINE FUMARATE 86 86 52 77
KETOCONAZOLE 86 85 52 232
TRIAMCINOLONE ACETONIDE 86 85 52 137
DONEPEZIL HCL 85 85 55 21
GLIPIZIDE ER 85 73 55 115
CARBIDOPA-LEVODOPA 83 83 57 85
RANITIDINE HCL 83 76 57 43
TAMSULOSIN HCL 81 69 59 29
GEMFIBROZIL 80 75 60 133
GLIMEPIRIDE 78 77 61 45
PRAMIPEXOLE DIHYDROCHLORIDE 78 78 61 187
MIRTAZAPINE 77 77 63 41
GLIPIZIDE XL 74 66 64 84
TAMIFLU 73 71 65 322
CYMBALTA 71 68 66 74
NOVOLOG MIX 70-30 68 64 67 257
SPIRIVA 68 48 67 48
ROPINIROLE HCL 66 58 69 124
OXYCONTIN 63 60 S2 70 138
SPIRONOLACTONE 61 61 71 65
JANUVIA 61 61 71 50
ZOSTAVAX 60 54 73 236
SEREVENT DISKUS 60 53 73 545
NAMENDA 60 60 73 36
PEN NEEDLE 57 56 76 119
VERAPAMIL ER 56 56 77 95
PRAVASTATIN SODIUM 55 55 78 15
HUMALOG 53 50 79 131
SYNTHROID 53 53 79 40
NOVOLOG FLEXPEN 53 38 79 212
NOVOLIN 70-30 53 53 79 268
OXYCODONE HCL 53 49 S2 79 67
PAROXETINE HCL 52 51 84 66
AMITRIPTYLINE HCL 51 33 R 85 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.